Phages work against both treatable and antibiotic-resistant bacteria. They may be used alone or with antibiotics and other drugs. Phages multiply and increase in number by themselves during treatment (only one dose may be needed).
Full Answer
What is phage therapy and how does it work?
Almost a decade before the discovery of penicillin, the controversial practice of phage therapy was being developed as a treatment for bacterial infections. Phages, short for bacteriophages, are bacteria-specific viruses that have been used as a treatment against pathogens such as Shigella dysenteriaeas early as 1919.
What infections can be treated with phage?
Conditions that may benefit from phage therapy Phage therapy may be very important in treating infections that don’t respond to antibiotics. For example, it may be used against a powerful Staphylococcus (staph) bacterial infection called MRSA. There have been successful cases of phage therapy use.
What are the limitations of phage therapy in the US?
In February 2019, the FDA approved the first clinical trial of intravenously administered phage therapy in the United States. As there are present limitations to phage therapy such as large natural variation of phages; and a regulatory structure in regards to the clinical application of phage.
Is phage therapy still used in France?
Although France is clearly a western country, most of the reviews of phage therapy have not mentioned the continuation of phage therapy in France, which had been ongoing with some vigor until the early 90s, with the commercial phages from d'Hérelle's previous company available until 1978.
How many phages are there?
Phages and their biology There are an estimated 1031 phage particles on the planet [3], an impossibly large number that translates into approximately a trillion phages for every grain of sand in the world.
Are phages used in hospitals?
The use of phages to kill pathogenic bacteria is an old practice to cure infectious diseases. The current antibiotic crisis has boosted phage therapy research, but its application in hospitals is still very limited.
How many phages have been sequenced?
Results As of January 2021, 14,244 complete phage genomes have been sequenced. The data set is dominated by phages that infect a small number of bacterial genera, with 75% of phages isolated only on 30 bacterial genera.
Are bacteriophages being used in medicine?
Phage therapy may be very important in treating infections that don't respond to antibiotics. For example, it may be used against a powerful Staphylococcus(staph) bacterial infection called MRSA. There have been successful cases of phage therapy use.
What countries use phage therapy?
Phage therapy is used in Russia, Georgia and Poland, and was used prophylactically for a time in the Soviet army. In Russia, extensive research and development soon began in this field. In the United States during the 1940s commercialization of phage therapy was undertaken by Eli Lilly and Company.
Is phage therapy available in the US?
Although scientists have been aware of phages and their ability to kill bacteria since 1917, the first U.S.-based clinical trials of phage therapy have only recently begun. Individual U.S. patients have received phage therapy, but only under emergency investigational new drug protocols.
What percent of viruses are bacteriophages?
Overall, phage genomes represent only about 15% of all viruses with known unique sequences and are thus vastly under-represented in the genome databases.
Are bacteriophages man made?
Summary: Researchers are using synthetic biology to reprogram bacterial viruses -- commonly known as bacteriophages -- to expand their natural host range. This technology paves the way for the therapeutic use of standardized, synthetic bacteriophages to treat bacterial infections.
Which is the largest bacteriophage?
One year ago, she reported that some of the largest phages, a group she called Lak phages, can be found in our guts and mouths, where they prey on gut and saliva microbiomes.
What is the cost of phage therapy?
Phage therapy is not clinically available in the United States, so those who are interested in phage therapy must travel to a clinic abroad or enroll in a clinical trial. The Phage Therapy Center in Georgia offers treatment to patients all around the world for about $3,000-$5,000, depending on the treatment.
Why is phage therapy not used?
Phage therapy has enormous potential, but unless we use the right viruses to attack a bacterial infection, phage therapy poses risks to infected patients, and to the general microbial environment. A common distinction is between lytic and lysogenic life cycles.
Is phage therapy better than antibiotics?
Phage therapy has fewer side effects than antibiotics. On the other hand, most antibiotics have a much wider host range. Some antibiotics can kill a wide range of bacterial species at the same time. The human immune system sometimes recognizes phages as “foreigners” and try to kill them.
What is a phage used for?
This means that a phage can be used to directly target disease-causing bacteria. For example, a strep bacteriophage will only kill bacteria that cause strep throat infections. Phages work against both treatable and antibiotic-resistant bacteria. They may be used alone or with antibiotics and other drugs.
Why are phages used in experimental studies?
One reason for this is because antibiotics are more easily available and are considered to be safer to use. There is ongoing research on the best way to use bacteriophages in people and animals. The safety of phage therapy also needs more research.
Why is phage therapy important?
Phage therapy may be very important in treating infections that don’t respond to antibiotics. For example, it may be used against a powerful Staphylococcus (staph) bacterial infection called MRSA. There have been successful cases of phage therapy use.
Why is phage therapy used in food?
Phage therapy in food prevents bacteria that can cause food poisoning, such as: Salmonella.
What are the benefits of phage therapy?
Phage therapy benefits. The benefits of phage therapy address the shortcomings of antibiotics. Just as there are many kinds of bacteria, there are several types of bacteriophages. But each kind of phage will only attack a certain bacterium. It won’t infect other kinds of bacteria.
Where are phages found?
They’re found in soil, sewage, water, and other places bacteria live. These viruses help keep bacteria growth in check in nature. Phage therapy might sound new, but it has been used for 100. Trusted Source. years.
Can phages be used in animals?
Phages are currently difficult to prepare for use in people and animals. It’s not known what dose or amount of phages should be used. It’s not known how long phage therapy may take to work. It may be difficult to find the exact phage needed to treat an infection.
When were phages first used?
The first known therapeutic use of phages occurred in 1919, when d'Herelle and several hospital interns ingested a phage cocktail to check its safety, then gave it to a 12-year-old boy with severe dysentery. The boy’s symptoms cleared up after a single dose and he fully recovered within a few days.
What was the purpose of the phages?
In the 1940s, the pharmaceutical company Eli Lilly produced phages for human use in the U.S., and they were marketed to treat a range of bacterial infections, including in wounds and upper respiratory infections.
Why is phage therapy so difficult?
That’s because phage therapy is almost 100 years old, making it difficult to patent and generate revenue to justify the initial development costs.
Where do bacteriophages come from?
Derived from the Greek words meaning “bacteria eater,” bacteriophages are abundant everywhere — on land, in water, within any form of life harboring their target. According to Forest Rowher, PhD, a microbial ecologist at San Diego State University, and colleagues in their book Life in Our Phage World, phages cause a trillion trillion successful ...
Where did phage therapy fall out of favor?
Phage therapy fell out of favor in the U.S. and most of Europe with the advent of antibiotics. Only in regions where antibiotics were not as easily accessed — namely what is now Russia, Poland and the Republic of Georgia — did phage therapy and commercial production continue.
When was phage therapy discovered?
Current day. Western scientists “re-discovered” phage therapy in the 1980s. Since then, the growing threat of antibiotic-resistant bacterial strains has continued to further interest in phage therapy as a potential alternative.
When was the first phase 1 clinical trial?
In the 2000s, human experiments began again and data from the first phase I clinical trial in the U.S. was published in 2009. That trial tested the safety of a cocktail of phages specific for E. coli, Staphylococcus aureus and Pseudomonas aeruginosa in 42 patients with chronic leg ulcers.
What is the use of phages?
The use of naturally-occurring phages to treat bacterial infection has a contentious history in western medicine. However, the emergent landscape of phage-based antimicrobials has advanced well beyond traditional methods.
What is phage therapy?
The practice of phage therapy, which uses bacterial viruses (phages) to treat bacterial infections, has been around for almost a century. The universal decline in the effectiveness of antibiotics has generated renewed interest in revisiting this practice. Conventionally, phage therapy relies on the use of naturally-occurring phages to infect ...
What are the two proteins that are used in phage lysis?
One of which is the transmembrane protein holin and the other is a peptidoglycan cell wall hydrolase called endolysin (lysin). These two proteins work together in triggering the lysis of the bacterial cell.
What is phage cocktail?
For treatment, lytic phages are compiled into preparations called “phage cocktails” which consist of multiple phages proven to have in vitroefficacy against the target pathogen. HISTORY OF PHAGE THERAPY.
Where is phage therapy performed?
Human trials for phage therapy have taken place for almost a century at several institutes in Eastern Europe, the most famous of which are the Eliava Institute of Bacteriophage and the Institute of Immunology and Experimental Therapy in Wroclaw, Poland.
How many people die from antimicrobial resistance in the world?
According to the United Kingdom government’s 2016 Review on Antimicrobial Resistance, an estimated 700000 people die each year globally from resistant infections with a projected cost of $100 trillion and a death toll of 10 million by 2050[7].
Do lysogenic phages have DNA?
In contrast to lytic phages, lysogenic phages integrate their genetic material into the bacterial chromosome in the form of an endogenous prophage (less commonly phage DNA can remain separate as a plas mid but still be stably transmitted across bacterial generations).
What is phage therapy?
Phage therapy, which can be described as a phage-mediated biocontrol of bacteria (or, simply, biocontrol), is the application of bacterial viruses—also bacteriophages or phages—to reduce densities of nuisance or pathogenic bacteria.
How does phage therapy help cholera?
Phage therapy for cholera was established as a helpful tool for treatment of cholera patients because phages killed large number of bacteria thus reducing burden of the pathogenic toxin and ultimately transmission of the disease (Summers, 2001 ). The details of phage therapy have been reviewed by Fazil and Singh (2011). The first report of phage therapy that used high doses of anticholera phages (100–200 phages per Vibrio) indicated that phages were able to kill cholera bacterium but not to complete many cycles of replication and amplification ( Summers, 2001 ). When phage therapy was conducted on ill patients in hospital and compared with tetracycline treatment and with fluid replacement alone as a control, it was noted that very high dose phage therapy was comparable to tetracycline in reducing the excretion of vibrios in stools ( Marcuk et al., 1971; Summers, 2001 ). This reduction, however, did not translate into overall clinical improvement, i.e., shorter duration of diarrhea and more rapid recovery ( Marcuk et al., 1971; Summers, 2001 ). Several problems were noted that complicated the evaluation of phage therapy in cholera: first was the discovery of diversity of serotypes of vibrios and the varying susceptibility of these bacteria to the phage stocks employed; second was the rapid transit of ingests phage through gastrointestinal tract of cholera patients, a fact that may have precluded second round of phage infection essential in low multiplicity of infection (MOI) therapy ( Summers, 2001 ). Several reports had shown utilization of phages in treatment of severe cases of cholera ( Marcuk et al., 1971 ). Considering the need for such prophylactic action at that time, the cholera phage therapy could be argued successful. The impetus for considering phage-mediated regulation would be the fact that phage-resistant strains rarely occur in natural habitats. Figure 5 shows counter strategies that can be used against multiple drug-resistant V. cholerae. It is conceivable that, although bacteria can develop resistance to phage, the resistance might be easier to overcome than resistance to antibiotics. Just as bacteria can evolve resistance, viruses can evolve to overcome resistance; however, the ability to evolve raises serious safety questions.
What is the name of the company that makes phage tablets?
An Eliava Institute spinoff pharma ceutical company, Biochimpharm, is licensed to manufacture and sell phage preparations in a tablet form against Shigella and Salmonella, including a highly specific pill against S. typhi and has also developed a new product, PhageBioderm, for wound treatment.
How many phages per vibrio?
The first report of phage therapy that used high doses of anticholera phages (100–200 phages per Vibrio) indicated that phages were able to kill cholera bacterium but not to complete many cycles of replication and amplification ( Summers, 2001 ).
What was the T4 phage used for?
Some were done for classification (phage typing) of bacterial pathogens, others for fundamental biological research (T4 phage), while still others were made expressly for phage therapy purposes, especially in the Soviet Union and Poland.
What was D'Herelle's phage therapy?
He treated human dysenteria, chicken cholera, bovine hemorrhagic fever, bubonic plague, cholera, and a variety of staphylococcal and streptococcal infections. His phage laboratory in Paris was devoted to phage therapy. Many people embarked on phage therapy. Spectacular successes and dismal failures ensued. The failures had many reasons: use of crude, uncontrolled, inactivated, or endotoxin-containing lysates, narrow host specificity of some phages; absence of bacteriological controls; and plain charlatanism. The literature on phage therapy peaked in 1930 and totaled 560 publications for 1920–40. At this time, antibiotics were introduced and interest in phage therapy quickly waned.
Why did phage therapy fail?
The failures had many reasons: use of crude, uncontrolled, inactivated, or endotoxin-containing lysates, narrow host specificity of some phages; absence of bacteriological controls; and plain charlatanism.
Where are phages used?
Phages are currently being used therapeutically to treat bacterial infections that do not respond to conventional antibiotics, particularly in Russia and Georgia. There is also a phage therapy unit in Wrocław, Poland, established in 2005, the only such centre in a European Union country. Phages are the subject of renewed clinical attention in ...
What is phage therapy?
Phage therapy is the use of bacteriophages to treat bacterial infections. This could be used as an alternative to antibiotics when bacteria develop resistance. Superbugs that are immune to multiple types of drugs are becoming a concern with the more frequent use of antibiotics. Phages can target these dangerous microbes without harming human cells ...
Why do phages kill bacteria?
Because phages replicate in vivo (in cells of living organism), a smaller effective dose can be used. This specificity is also a disadvantage: a phage will kill a bacterium only if it matches the specific strain. Consequently, phage mixtures ("cocktails") are often used to improve the chances of success.
Why are phage mixtures used?
Consequently, phage mixtures ("cocktails") are often used to improve the chances of success. Alternatively, samples taken from recovering patients sometimes contain appropriate phages that can be grown to cure other patients infected with the same strain.
Why was Phagoburn terminated?
aeruginosa wound infection in France and Belgium in 2015–17, was terminated early because the phage therapy was not effective. In July 2020, the FDA approved the first clinical trial of nebulized phage therapy in the United States. [2] .
What are the advantages and disadvantages of phages?
Advantages include reduced side-effects and reduced risk of the bacterium's developing resistance. Disadvantages include the difficulty of finding an effective phage for a particular infection.
What is the therapeutic use of bacteriophages?
Therapeutic use of bacteriophages to treat pathogenic bacterial infections. Phage injecting its genome into bacterial cell. An electron micrograph of bacteriophages attached to a bacterial cell. These viruses are the size and shape of coliphage T1. Phage therapy, viral phage therapy, or phagotherapy is the therapeutic use ...
What is a phage?
Bacteriophages ( phages) are natural biological entities that kill bacteria with species specific precision, rendering them attractive for therapeutic purposes. Phages were discovered over a century ago, but, after antibiotic discovery, their use as antimicrobials dwindled. Interest in phage therapy has, however, ...
What should be the focus of preclinical studies for human phage therapy?
Preclinical studies for human phage therapy should focus on initial selection of phages with suitable genomic and phenotypic properties. The phages should be naturally occurring strictly lytic or engineered phages; lacking genes that encode for antibiotic resistance or lysogeny control.
Do phages replicate?
Phages also replicate at infection sites, ensuring a continuous dose supply and they can penetrate difficult to treat biofilms [7]. These biological advantages seem attractive with the backdrop of continuing development of bacterial resistance to major frontline antibiotics.
What is the bacterium that causes a death rate of 40-80%?
Enterobacter sakazakii is an opportunistic pathogen, causes life-threatening infection in intestine and nervous system with 40-80% mortality rate in infant. This bacterium is mainly found in milk powder and other infant formula. Other food sources for this bacterium are cereal fruits vegetables milk meat and fish. Two phages – ESP 1–3 and ESP 732–1 – cause eradication of E. sakazakii at phage level of 10 9 cfu/ml. As inhibition by phage ESP 1–3 and ESP 732–1 occurs at 24°C and at any temperature respectively, phage ESP 732–1 has greater effectiveness than phage ESP 1–3.
What is BCP-1 used for?
BCP-1 phage is used against Bacillus cereus a food poisoning agent causing diarrhea and vomiting. This bacteria is found on various foods such as milk, cheese, cereal, rice, red pepper and fermented food. More than 10 4 cfu/g of B. cereus can causes contamination in these foods. As BCP-1 is only specific to B. cereus, it can’t inhibit other gram positive or negative strains of bacteria. Therefore, it can’t eradicate other beneficial microorganisms.
